Search by Drug Name or NDC

NDC 61703-0349-09 Irinotecan Hydrochloride 20 mg/mL Details

Irinotecan Hydrochloride 20 mg/mL

Irinotecan Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is IRINOTECAN HYDROCHLORIDE.

MedlinePlus Drug Summary

Irinotecan is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine). Irinotecan is in a class of antineoplastic medications called topoisomerase I inhibitors. It works by stopping the growth of cancer cells.

Related Packages: 61703-0349-09
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Irinotecan Injection

Product Information

NDC	61703-0349
Product ID	61703-349_97675447-8e56-4d7d-a8ab-677b2897fab0
Associated GPIs	21550040102030 21550040102025 21550040102040
GCN Sequence Number	062174
GCN Sequence Number Description	irinotecan HCl VIAL 100 MG/5ML INTRAVEN
HIC3	V3E
HIC3 Description	ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS
GCN	97956
HICL Sequence Number	010778
HICL Sequence Number Description	IRINOTECAN HCL
Brand/Generic	Generic
Proprietary Name	Irinotecan Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Irinotecan Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	20
Active Ingredient Units	mg/mL
Substance Name	IRINOTECAN HYDROCHLORIDE
Labeler Name	Hospira, Inc.
Pharmaceutical Class	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077915
Listing Certified Through	2024-12-31

Package

NDC 61703-0349-09 (61703034909)

Pricing Information	N/A
NDC Package Code	61703-349-09
Billing NDC	61703034909
Package	1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-09) / 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date	2008-02-27
NDC Exclude Flag	N